Consolidated Statement Of Income

Cyfuse Biomedical K.K. - Filing #7546761

Concept 2023-01-01 to
2023-06-30
2022-01-01 to
2022-06-30
Consolidated statement of income
Statement of income
Net sales
18,272,000 JPY
332,504,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
57,937,000 JPY
57,900,000 JPY
Rent expenses on land and buildings
12,519,000 JPY
27,645,000 JPY
Cost of sales
8,691,000 JPY
120,751,000 JPY
Operating expenses
Selling, general and administrative expenses
373,237,000 JPY
308,727,000 JPY
Operating expenses
Gross profit (loss)
9,580,000 JPY
211,752,000 JPY
Operating profit (loss)
-363,656,000 JPY
-96,974,000 JPY
Net sales
Ordinary profit (loss)
-362,953,000 JPY
-76,127,000 JPY
Operating expenses
Research and development expenses
182,566,000 JPY
137,456,000 JPY
General and administrative expenses
Salaries
Selling, general and administrative expenses
Non-operating income
Interest income
18,000 JPY
19,000 JPY
Other
527,000 JPY
400,000 JPY
Non-operating income
11,060,000 JPY
29,566,000 JPY
Cost of sales
Extraordinary losses
JPY
37,807,000 JPY
Other
JPY
0 JPY
Non-operating expenses
10,358,000 JPY
8,718,000 JPY
Interest expenses
4,987,000 JPY
2,735,000 JPY
Non-operating expenses
Profit (loss) before income taxes
-362,953,000 JPY
-113,934,000 JPY
Gross profit
Income taxes - current
1,652,000 JPY
1,004,000 JPY
Extraordinary losses
Income taxes
1,652,000 JPY
1,004,000 JPY
Profit (loss)
-364,606,000 JPY
-114,938,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.